Progression-free survival
Showing 51 - 75 of >10,000
Independent Living, Disability Free Survival, Elderly Trial in Australia (Atorvastatin, Placebo (for Atorvastatin))
Recruiting
- Independent Living
- +3 more
- Atorvastatin
- Placebo (for Atorvastatin)
-
Hobart, Tasmania, Australia
- +5 more
Nov 28, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)
Terminated
- Metastatic Castration-resistant Prostate Cancer
- Enzalutamide during Lead-in Period
- +5 more
-
Myrtle Beach, South CarolinaResearch Site
Sep 9, 2022
Surgical Complications and DFS in Obese Rectal Cancer Patients
Recruiting
- Obesity, Morbid
- +2 more
- BIB positioning
-
Naples, ItalyNunzio Velotti
Sep 27, 2023
Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)
Recruiting
- Liver Metastasis
- Colon Cancer
- Icosapent Ethyl
- Placebo
-
Oxford, Oxfordshire, United Kingdom
- +12 more
Nov 7, 2022
Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,
Recruiting
- Soft Tissue Sarcoma Adult
- +2 more
-
Aarhus, Denmark
- +3 more
Jul 23, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Alkmaar, Netherlands
- +27 more
Jun 27, 2023
Immunotherapy-related CRP Kinetics in Early and Metastatic
Recruiting
- TNBC - Triple-Negative Breast Cancer
-
Tuebingen, GermanyDepartment of Women's Health
Jun 13, 2023
Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With
Completed
- DLBCL
- Old Age; Debility
-
Homburg, Saarland, GermanySaarland University Medical Center
Nov 20, 2023
Esophageal Cancer Trial in Shanghai (Propofol-based total intravenous anesthesia, Sevoflurane intravenous anesthesia)
Recruiting
- Esophageal Cancer
- Propofol-based total intravenous anesthesia
- Sevoflurane intravenous anesthesia
-
Shanghai, ChinaShanhai Chest Hospital
Aug 26, 2021
Can Second Resection for pT1 Bladder Cancer be Avoided After
Recruiting
- Bladder Cancer Stage I
- Avoid second resection after initial complete resection
-
Mansoura, Dakahlia, EgyptUrology and nephrology center, Mansoura University
Aug 2, 2023
NSCLC Trial (Ivonescimab Injection, Pembrolizumab Injection)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Ivonescimab Injection
- Pembrolizumab Injection
- (no location specified)
Jun 9, 2023
Non-Small-Cell Lung Carcinoma Trial in Hwasun (Nicotinamide)
Unknown status
- Non-Small-Cell Lung Carcinoma
-
Hwasun, Chonnam, Korea, Republic ofChonnam National University Hwasun Hospital
Jan 23, 2020
Immunotherapy-related CRP Kinetics in Metastatic Gynecological
Recruiting
- Gynecological Malignancies
- +4 more
-
Tuebingen, GermanyDepartment of Women's Health
Jun 13, 2023
Immune Activation and Latent HIV Reservoir Size Between People
Enrolling by invitation
- HIV-1-infection
- +3 more
- Venipuncture
- +4 more
-
Seattle, WashingtonUniversity of Washington Positive Research and the Gastroenterol
Oct 14, 2022
SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)
Recruiting
- SCCHN
- Squamous Cell Carcinoma
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 5, 2023
Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))
Recruiting
- Hepatocellular Carcinoma
- Fruquintinib
- +2 more
-
Hangzhou, Zhejiang, ChinaGuoliang Shao
Aug 1, 2023
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)
Completed
- HER2-positive Breast Cancer
- +5 more
-
Tucson, Arizona
- +15 more
Dec 22, 2022
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
T1 Squamous Cell Carcinomas of the Lip
Active, not recruiting
- Lip
- +9 more
-
Nijmegen, Gelderland, Netherlands
- +2 more
Nov 2, 2022
Liquid Biopsy in High-grade Gliomas and Meningiomas
Recruiting
- High Grade Glioma
- High Grade Meningioma
-
Milano, MI, Italy
- +4 more
Nov 29, 2022